“…110, 113–118 Smoking trsAUD also showed significantly less recovery than non-smoking trsAUD in: a) brain metabolite markers of neuronal integrity and cell membrane turnover/synthesis in the frontal and medial temporal lobes, frontal gray matter (GM) perfusion and microstructural integrity in the frontal, temporal and parietal white matter (WM), as well as in neurocognition, over 1-month of abstinence, 119–122 and b) multiple domains of neurocognition over 1 123 and 9–12 months of abstinence. 124 Recently, we also observed that smoking trsAUD relative to non-smoking trsAUD had thinner cortex and lower N-acetylaspartate levels (marker of neuronal integrity), in anterior frontal and temporal regions at entry into treatment. 125 Recent analyses also indicated that smoking trsAUD showed greater age-related volume loss than non-smoking trsAUD in the anterior frontal regions and the insula, as well as poorer performance with increasing age on measures of learning and memory, cognitive efficiency, executive functions, processing speed, and fine motor skills at 1-month of abstinence.…”